Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.

ABSTRACT:

Background

Myostatin (Mstn) is a negative regulator of muscle growth whose inhibition promotes muscle growth and regeneration. Dystrophin-deficient mdx mice in which myostatin is knocked out or inhibited postnatally have a less severe phenotype with greater total mass and strength and less fibrosis and fatty replacement of muscles than mdx mice with wild-type myostatin expression. Dogs with golden retriever muscular dystrophy (GRMD) have previously been noted to have increased muscle mass and reduced fibrosis after systemic postnatal myostatin inhibition. Based partly on these results, myostatin inhibitors are in development for use in human muscular dystrophies. However, persisting concerns regarding the effects of long-term and profound myostatin inhibition will not be easily or

SUBMITTER: Kornegay JN 

PROVIDER: S-EPMC4819282 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature